396 related articles for article (PubMed ID: 25728647)
1. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
2. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
Flück CE; Nicolo C; Pandey AV
Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
[TBL] [Abstract][Full Text] [Related]
3. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
4. Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.
Marohnic CC; Panda SP; McCammon K; Rueff J; Masters BS; Kranendonk M
Drug Metab Dispos; 2010 Feb; 38(2):332-40. PubMed ID: 19884324
[TBL] [Abstract][Full Text] [Related]
5. Impeded electron transfer from a pathogenic FMN domain mutant of methionine synthase reductase and its responsiveness to flavin supplementation.
Gherasim CG; Zaman U; Raza A; Banerjee R
Biochemistry; 2008 Nov; 47(47):12515-22. PubMed ID: 18980384
[TBL] [Abstract][Full Text] [Related]
6. Structural and Kinetic Studies of Asp632 Mutants and Fully Reduced NADPH-Cytochrome P450 Oxidoreductase Define the Role of Asp632 Loop Dynamics in the Control of NADPH Binding and Hydride Transfer.
Xia C; Rwere F; Im S; Shen AL; Waskell L; Kim JP
Biochemistry; 2018 Feb; 57(6):945-962. PubMed ID: 29308883
[TBL] [Abstract][Full Text] [Related]
7. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
[TBL] [Abstract][Full Text] [Related]
8. NADPH-cytochrome P450 oxidoreductase. Structural basis for hydride and electron transfer.
Hubbard PA; Shen AL; Paschke R; Kasper CB; Kim JJ
J Biol Chem; 2001 Aug; 276(31):29163-70. PubMed ID: 11371558
[TBL] [Abstract][Full Text] [Related]
9. Mutants of Cytochrome P450 Reductase Lacking Either Gly-141 or Gly-143 Destabilize Its FMN Semiquinone.
Rwere F; Xia C; Im S; Haque MM; Stuehr DJ; Waskell L; Kim JJ
J Biol Chem; 2016 Jul; 291(28):14639-61. PubMed ID: 27189945
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan 697 modulates hydride and interflavin electron transfer in human methionine synthase reductase.
Meints CE; Gustafsson FS; Scrutton NS; Wolthers KR
Biochemistry; 2011 Dec; 50(51):11131-42. PubMed ID: 22097960
[TBL] [Abstract][Full Text] [Related]
11. Biochemical analysis of mutations in P450 oxidoreductase.
Pandey AV
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1186-91. PubMed ID: 17073782
[TBL] [Abstract][Full Text] [Related]
12. Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding.
Gutierrez A; Paine M; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2002 Apr; 41(14):4626-37. PubMed ID: 11926825
[TBL] [Abstract][Full Text] [Related]
13. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
[TBL] [Abstract][Full Text] [Related]
14. Proximal FAD histidine residue influences interflavin electron transfer in cytochrome P450 reductase and methionine synthase reductase.
Meints CE; Parke SM; Wolthers KR
Arch Biochem Biophys; 2014 Apr; 547():18-26. PubMed ID: 24589657
[TBL] [Abstract][Full Text] [Related]
15. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
Yamamoto K; Kimura S; Shiro Y; Iyanagi T
Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
[TBL] [Abstract][Full Text] [Related]
16. Aromatic substitution of the FAD-shielding tryptophan reveals its differential role in regulating electron flux in methionine synthase reductase and cytochrome P450 reductase.
Meints CE; Simtchouk S; Wolthers KR
FEBS J; 2013 Mar; 280(6):1460-74. PubMed ID: 23332101
[TBL] [Abstract][Full Text] [Related]
17. The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR.
Vincent B; Morellet N; Fatemi F; Aigrain L; Truan G; Guittet E; Lescop E
J Mol Biol; 2012 Jul; 420(4-5):296-309. PubMed ID: 22543241
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P.
Dhir V; Ivison HE; Krone N; Shackleton CH; Doherty AJ; Stewart PM; Arlt W
Mol Endocrinol; 2007 Aug; 21(8):1958-68. PubMed ID: 17505056
[TBL] [Abstract][Full Text] [Related]
19. Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase.
Pandey AV; Kempná P; Hofer G; Mullis PE; Flück CE
Mol Endocrinol; 2007 Oct; 21(10):2579-95. PubMed ID: 17595315
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
